Search

Subject 6 -- 3 -- 3 -- 1 -- 1

1. Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP). Issue 28 (1st October 2022)

Authors:
Gallagher, Emily J.; Moore, Heather; Lacouture, Mario E.; Dent, Susan Faye; Farooki, Azeez; Goncalves, Marcus D.; Isaacs, Claudine; Johnston, Abigail; Juric, Dejan; Quandt, Zoe; Spring, Laura; Berman, Brian; Decker, Melanie; Hortobagyi, Gabriel N.; Kaffenberger, Benjamin; Kwong, Bernice Y.; Pluar...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 28(2022)Supplement
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search